Creo Medical Share Discussion Threads

[slicethepie] 04/10/2024 13:18

It's either that or else the children who did the raise at cavendish and deutsche realised they are on half term next week! Please write to the company telling them to slash the fees payable to these clowns

[skinny] 04/10/2024 12:28

A link to the above ~:-

[bmcollins] 04/10/2024 10:51

Don't know if this is old news but AJ Bell just sent me an email saying that the retail offer has been extended until 17 Oct.
Clearly nobody will buy at 24p when market is lower but I guess it's a signal that they intend to get the share price up above 24p in next 2 weeks ?

[bmcollins] 04/10/2024 10:38

@Dr B
Google;

baillie gifford creo medical at the spearhead of surgery

and you will see it
Hope this helps

[dr biotech] 04/10/2024 09:44

Do you have a link for that? I can't find it.

[bmcollins] 04/10/2024 09:15

Citywire this morning are running an article by Baillee Gifford (holders of Creo from the outset) on Creo, a very interesting piece, imho.

[malcolmz1] 03/10/2024 17:09

Chart turning. Bottom is in.

[bjfanc] 02/10/2024 11:13

So selling for circa £25 million cash now means a forfeit of £1.5million.

[bmcollins] 02/10/2024 11:11

@Dr B
Thanks for those thoughts, I fear that they are pretty much on the money, if one is allowed to use that expression about Creo ?
The greed of the directors was something that I stupidly didn't look at when I did my due diligence, their avarice is jaw dropping...

[dr biotech] 02/10/2024 10:05

Will be interesting to see how much if anything is raised in the public offering. You'd think the answer would be 0, but there are always a few mugs about. I've followed the offers made through Primary bid - mostly but not entirely a list of barge pole companies wanting to raise money to pay their directors. One of them (BMN) offered the shares at 0.3p when the market buy price was something like 0.24 - and still raised a few tens of thousands. Their share price as of course dropped since then and anyone who took part on the placing is in the 90% club.

Of course those who took part in the early placings here are sharing the same liferaft.


---
To answer the previous question, the sale of the consumables business will result in a loss of about £1.5m of cash per year. That would of course push time to break even back a bit here, but according to their previous forecasts only by a year, if that. Its the lack of sales that has been the real issue and delayed forecast breakeven to 2028. It will also cause a huge slump in revenue as currently all creo revenue is counted and as they will become a minority holder I believe that will then drop the consumables revenue to zero. I'm not an accountant so I may be wrong. Obviously they would have their 49% holding that would get a dividend at 100% profit instead.

The one possible saviour would be a deal with a kampative partner. When I was at the AGM I asked what did they need to really drive sales - the reply was clinical data. Whilst the ball is rolling its not going to be anytime soon.

[slicethepie] 01/10/2024 21:41

I apologise for repeating this but this poorly handled placing is bad for the uk market in general. For two quality brokers to make such a mess is unacceptable. They both had plenty of time to get their books in the right position and to understand the share register. At a minimum they should refund creo 50% of their fees. I am pretty sure all the investors who got legged over will cut their commission for a few months.

[malcolmz1] 01/10/2024 19:15

I'm in for another 81k shares at 21p. Buy when others are fearful

[bmcollins] 01/10/2024 17:57

I added at just over 22p but then I guessed I'd be a Diana Ross for the uptick (I'm still waiting)...

[malcolmz1] 01/10/2024 17:39

Wait and see. This is a bargain at 21p.

[bmcollins] 01/10/2024 17:26

Are you mystic meg or mystic malc ?

[malcolmz1] 01/10/2024 17:12

Once the sale is complete the share price will bounce back into 30s. Easy money to be made here. I wouldn't worry about 2028 either. The company will be snapped up well before then.

[bjfanc] 01/10/2024 16:20

Following the Sale and deconsolidation of Creo Europe and based on current core Creo sales growth only, being a prudent forecast, we now expect EBITDA breakeven to be in 2028.Hard to know, how much time the sale added.

[nimbo10] 01/10/2024 15:48

Dr Biotech your post 837, I re read the results and they do say 2028 breakeven just on core products, the previous stance of breakeven in 2025 must have been for all the company, which includes the parts of business they just sold off. Looks like they had to rewrite this following the sale news?

[dr biotech] 01/10/2024 15:02

Well at the current share price the company is worth about the same as its cash and the valuation of the consumables business. So almost no value at all to the core products.

Cannacord are probably still having to reduce too. That could be forced redemptions from their IHT funds. Could really do with Labour delivering their budget sooner and getting the uncertainty out of the way.

Perhaps they should have offered their stake to Intuitive or CMR. A £5m investment would be a good strategic move from Intuitive to secure good access to current and future products (that they are clearly interested in), it would boost the share price and get rid of the seller. Shame the city never really works like that.

[gsargood] 01/10/2024 14:24

As of today agreed, the last placement at 20p it dropped down after then pretty quickly was at 50p … I guess when the money comes in from the sale in January they will be in a good position financially

[bmcollins] 01/10/2024 14:10

@slice
Indeed, I have to agree, currently offered at under 21.25p !
This has been a debacle of note
If anyone has been looking at Creo in terms of making an offer surely now is the time to make it, but there's 2 hopes of that happening, no hope & Bob Hope...

[slicethepie] 01/10/2024 13:44

Absolute pi## poor broking here, despite £1m of fees their brokers cannot create demand and have ruined the retail offer. If I were creo I would demand a 50% cut in fees.

[its the oxman] 01/10/2024 13:16

Share price says otherwise but hope time proves you right. Was tempted to buy once but consider it a lucky miss now.

[gsargood] 01/10/2024 13:06

Agree with Dr Biotech , the fact that the chairman has purchased circa 3 million shares is a great indication of positive trajectory one would assume

[bmcollins] 01/10/2024 09:09

Apologies I missed the 07.00 RNS today, placing has been completed so any retail investor wishing to top up/average down can do so at a lower price now than the retail offer.